G1/S transition

Last updated
Depiction of regulation at the G1/S transition point in cell cycle progression G1-S cell cycle regulation.jpg
Depiction of regulation at the G1/S transition point in cell cycle progression
Cell cycle Cell Cycle 2-2.svg
Cell cycle
Signal transduction pathways influencing gene regulation and cellular proliferation. Signal transduction v1.png
Signal transduction pathways influencing gene regulation and cellular proliferation.

The G1/S transition is a stage in the cell cycle at the boundary between the G1 phase, in which the cell grows, and the S phase, during which DNA is replicated. [1] It is governed by cell cycle checkpoints to ensure cell cycle integrity and the subsequent S phase can pause in response to improperly or partially replicated DNA. [2] During this transition the cell makes decisions to become quiescent (enter G0), differentiate, make DNA repairs, or proliferate based on environmental cues and molecular signaling inputs. [3] The G1/S transition occurs late in G1 and the absence or improper application of this highly regulated checkpoint can lead to cellular transformation and disease states such as cancer. [4] [1]

Contents

During this transition, G1 cyclin D-Cdk4/6 dimer phosphorylates retinoblastoma releasing transcription factor E2F, which then drives the transition from G1 to S phase. The G1/S transition is highly regulated by transcription factor p53 in order to halt the cell cycle when DNA is damaged. [5]

It is a "point of no return" beyond which the cell is committed to dividing; in yeast this is called the Start point, and in multicellular eukaryotes it is termed the restriction point (R-Point). [2] [6] If a cell passes through the G1/S transition the cell will continue through the cell cycle regardless of incoming mitogenic factors due to the positive feed-back loop of G1-S transcription. [2] Positive feed-back loops include G1 cyclins and accumulation of E2F in multicellular eukaryotes, and the accumulation of SBF in yeast cells. [2]

Cell cycle overview

The cell cycle is a process in which an ordered set of events leads to the growth and division into two daughter cells. The cell cycle is a cycle rather than a linear process because the two daughter cells produced repeat the cycle. This process contains two main phases, interphase, in which the cell grows and synthesizes a copy of its DNA, and the mitotic (M) phase, during which the cell separates its DNA and divides into two new daughter cells. [7] Interphase is further broken down into the G1 (GAP 1) phase, S (Synthesis) phase, G2 (GAP 2) phase and the mitotic (M) phase which in turn is broken down into mitosis and cytokinesis. Following cytokinesis, during G1 phase the cells monitor environment for the potential growth factors, grow larger and once achieve the threshold size (rRNA and overall protein content characteristic for a given cell type) they start progression through S phase. [8] During S phase, the cell also duplicates the centrosome, or microtubule-organizing center, which is critical for DNA separation in the M phase. After complete synthesis of its DNA, the cell enters the G2 phase where it continues to grow in preparation for mitosis. Following interphase, the cell transitions into mitosis, containing four sub stages: prophase, anaphase, metaphase, and telophase. In mitosis, DNA condenses into chromosomes, which are lined up and separated by the mitotic spindle. [9] After duplicate DNA is separated on opposite ends of the cell, the cytoplasm of the cell is split in two during cytokinesis resulting in two daughter cells. [7]

The yeast cell cycle goes through similar stages however there is the additional factor of mating to consider. A haploid cell arrests in G1 if it has not passed Start and is exposed to enough mating pheromone, but will progress into S-phase if both of those conditions are not met. [10]

Cell cycle regulation in mammalian cells

As with most processes in the body, the cell cycle is highly regulated to prevent the synthesis of mutated cells and uncontrolled cell division that leads to tumor formation. [11] The cell cycle control system is biochemically based so that the proteins of the mitosis promoting factor (MPF) control the transition from one phase to the next based on a series of checkpoints. MPF is a protein dimer made up of cyclin and cyclin-dependent kinase (Cdk), a serine and threonine kinase, which come together at different points in the cycle to control cell progression through the cycle. When cyclin binds to Cdk, Cdk becomes activated and phosphorylates serine and threonine on other proteins causing the activation and degradation of other proteins allowing the cell to transition through the cell cycle. [7]

G1/S transition

In mid to late G1 phase, cyclin D bound to Cdk4/6, activates the expression of the S phase cyclin-Cdk components; however, the cell does not want S phase cyclins to become active in G1. [7] Therefore, an inhibitor, protein Slc-1, is present that interacts with the dimer so that the S phase cyclin-Cdk dimer remains inactive until the cell is ready to move into S phase. [7] After the cell has grown and is ready to synthesize DNA, G1 cyclin-Cdks phosphorylate the S phase cyclin inhibitor signaling ubiquitination, resulting in the addition of groups to the inhibitor. Ubiquitination of the inhibitor signals the SCF/proteasome to degrade the inhibitor releasing and allowing the S phase cyclin-Cdk to become activated and the cell moves into S phase. Once in S phase, cyclin-Cdks phosphorylate several factors on the replication complex promoting DNA replication by causing inhibitory proteins to fall off of replication complexes or through activation of components on the replication complex to induce DNA replication initiation. [12]

Retinoblastoma protein (pRB) and the G1/S transition

Crystal structure of the retinoblastoma tumour suppressor protein bound to E2F RB1.JPG
Crystal structure of the retinoblastoma tumour suppressor protein bound to E2F

Another dimer present during mid G1 is composed of retinoblastoma protein (pRB) and transcription factor E2F. When pRb is bound to E2F, E2F is inactive. As cyclin D is synthesized and activates Cdk4/6, the cyclin-Cdk targets Rb protein for phosphorylation. Upon phosphorylation, pRb changes conformation so that E2F is released and activated, binding to upstream regions of genes, initiating expression. Specifically, E2F drives the expression of other cyclins, including cyclin E and A, and genes necessary for DNA replication. Cyclin E either phosphorylates more pRb, thereby completing inactivation, to further activate E2F and promote the expression of more Cyclin E, or it has the ability to increase expression of itself. These interactions create a positive feedback loop. Cyclin E also interacts with Cdk2 driving the cell cycle to progress from G1 to S phase. [13] E2F also targets Skp2, an F-box protein that targets the CDK inhibitor p27 for degradation, creating a third positive feedback loop. These positive feedback loops are the key to creating the all-or-nothing, switch-like transition between G1 and S-phase, and their components cyclin E1, cyclin E2, Skp2, and E2F1 are all transcribed early on at the G1/S transition. [14]

The role of retinoblastoma in tumor formation

Retinoblastoma (Rb) is a cancer of the eye due to a mutant pRb protein. [7] When pRb is mutated it becomes nonfunctional and is not able to inhibit the expression of transcription factor E2F. Therefore, E2F is always active and driving the cell cycle to progress from G1 to S phase. As a result, cell growth and division is unregulated causing tumor formation in the eye. [11]

Cell cycle checkpoints

To ensure proper cell division, the cell cycle utilizes numerous checkpoints to monitor cell progression and halt the cycle when processes go awry. These checkpoints include four DNA damage checkpoints, one unreplicated DNA checkpoint at the end of G2, one spindle assembly checkpoint in mitosis, and a chromosome segregation checkpoint during mitosis. [11]

p53 as a regulator

Conceptualization of p53 pathway. P53 Pathway.png
Conceptualization of p53 pathway.
p53-DNA damage complex Tumour suppressor p53-DNA complex.jpg
p53-DNA damage complex

Between G1 and S phase, three DNA damage checkpoints occur to ensure proper growth and synthesis of DNA prior to cell division. Damaged DNA during G1, before entry into S phase, and during S phase result in the expression of ATM/R protein. ATM/R protein then stabilizes and activates transcription factor p53 so that it can bind to upstream regions of genes, inducing the expression of proteins including p21CIP. p21CIP binds to and inhibits any cyclin-cdk present in the cell cycle, halting the cycle until DNA damage can be corrected. [15]

Additional processes at DNA damage checkpoints

Of the four DNA damage checkpoints, two have an additional process for monitoring DNA damage other than activating p53. Before entry into S phase and during S phase, ATM/R also activates Chk1/2 that inhibits Cdc25A, a protein responsible for activating cyclin-Cdk dimers. Without cyclin dimer activation, the cell cannot transition through the cycle. These two checkpoints have additional processes for regulation because replicating damaged DNA in S phase can be deleterious to the cell and more importantly, the organism. [7]

Cell cycle regulation in budding yeast

Cell cycle regulation is just as important in yeast cells which respond to nutrient and mating pheromone levels in their environment in order to grow, divide and reproduce appropriately.

The Start point is the moment in the yeast cell cycle that determines the all-or-nothing commitment to undergo DNA replication. Input signals promote cyclin synthesis which drives cyclin-dependent kinase (CDK) activity past a threshold that triggers a self-sustaining positive feedback loop that pushes the cell into S-phase. [14] This is a sharp switch due to the genes involved in the positive feedback loop being transcribed before other genes transcribed under the same transcriptional factor.

G1/S transition

Cln3 binds and activates CDK1. The Cln3-CDK1 complex then inactivates the transcriptional inhibitor Whi5 by phosphorylation which causes it to release from the transcriptional factor SBF. The size of a yeast cell and its time spent in G1 are roughly proportional. This is partly governed by inhibitor dilution associated with Whi5. Once no longer inhibited, SBF goes on to weakly promote transcription of downstream G1 cyclins CLN1 and CLN2. Cln1 and Cln2 form a positive feedback loop by further inactivating Whi5 and concurrently activating SBF as well as MBF, driving the expression of over 200 genes, including S-phase cyclins that initiate DNA replication. An additional positive feedback loop is created by Swi4, a component of SBF that is itself a target of SBF. Together, this sudden activation of the G1 cyclin positive feedback loop defines the Start point that is key to making the G1/S transition distinct and abrupt. Once the CDK activity threshold is passed and feedback is activated, fluctuations in the upstream input signals no longer have an influence on the fate of the cell cycle. [14]

See also

Related Research Articles

<span class="mw-page-title-main">Cell cycle</span> Series of events and stages that result in cell division

The cell cycle, or cell-division cycle, is the sequential series of events that take place in a cell that causes it to divide into two daughter cells. These events include the growth of the cell, duplication of its DNA and some of its organelles, and subsequently the partitioning of its cytoplasm, chromosomes and other components into two daughter cells in a process called cell division.

G<sub>1</sub> phase First growth phase in the eukaryotic cell cycle

The G1 phase, gap 1 phase, or growth 1 phase, is the first of four phases of the cell cycle that takes place in eukaryotic cell division. In this part of interphase, the cell synthesizes mRNA and proteins in preparation for subsequent steps leading to mitosis. G1 phase ends when the cell moves into the S phase of interphase. Around 30 to 40 percent of cell cycle time is spent in the G1 phase.

<span class="mw-page-title-main">S phase</span> DNA replication phase of the cell cycle, between G1 and G2 phase

S phase (Synthesis phase) is the phase of the cell cycle in which DNA is replicated, occurring between G1 phase and G2 phase. Since accurate duplication of the genome is critical to successful cell division, the processes that occur during S-phase are tightly regulated and widely conserved.

G<sub>2</sub> phase Second growth phase in the eukaryotic cell cycle, prior to mitosis

G2 phase, Gap 2 phase, or Growth 2 phase, is the third subphase of interphase in the cell cycle directly preceding mitosis. It follows the successful completion of S phase, during which the cell’s DNA is replicated. G2 phase ends with the onset of prophase, the first phase of mitosis in which the cell’s chromatin condenses into chromosomes.

<span class="mw-page-title-main">Restriction point</span> Animal cell cycle checkpoint

The restriction point (R), also known as the Start or G1/S checkpoint, is a cell cycle checkpoint in the G1 phase of the animal cell cycle at which the cell becomes "committed" to the cell cycle, and after which extracellular signals are no longer required to stimulate proliferation. The defining biochemical feature of the restriction point is the activation of G1/S- and S-phase cyclin-CDK complexes, which in turn phosphorylate proteins that initiate DNA replication, centrosome duplication, and other early cell cycle events. It is one of three main cell cycle checkpoints, the other two being the G2-M DNA damage checkpoint and the spindle checkpoint.

E2F is a group of genes that encodes a family of transcription factors (TF) in higher eukaryotes. Three of them are activators: E2F1, 2 and E2F3a. Six others act as repressors: E2F3b, E2F4-8. All of them are involved in the cell cycle regulation and synthesis of DNA in mammalian cells. E2Fs as TFs bind to the TTTCCCGC consensus binding site in the target promoter sequence.

<span class="mw-page-title-main">Cell cycle checkpoint</span> Control mechanism in the eukaryotic cell cycle

Cell cycle checkpoints are control mechanisms in the eukaryotic cell cycle which ensure its proper progression. Each checkpoint serves as a potential termination point along the cell cycle, during which the conditions of the cell are assessed, with progression through the various phases of the cell cycle occurring only when favorable conditions are met. There are many checkpoints in the cell cycle, but the three major ones are: the G1 checkpoint, also known as the Start or restriction checkpoint or Major Checkpoint; the G2/M checkpoint; and the metaphase-to-anaphase transition, also known as the spindle checkpoint. Progression through these checkpoints is largely determined by the activation of cyclin-dependent kinases by regulatory protein subunits called cyclins, different forms of which are produced at each stage of the cell cycle to control the specific events that occur therein.

Cyclin A is a member of the cyclin family, a group of proteins that function in regulating progression through the cell cycle. The stages that a cell passes through that culminate in its division and replication are collectively known as the cell cycle Since the successful division and replication of a cell is essential for its survival, the cell cycle is tightly regulated by several components to ensure the efficient and error-free progression through the cell cycle. One such regulatory component is cyclin A which plays a role in the regulation of two different cell cycle stages.

<span class="mw-page-title-main">Cyclin D</span> Member of the cyclin protein family

Cyclin D is a member of the cyclin protein family that is involved in regulating cell cycle progression. The synthesis of cyclin D is initiated during G1 and drives the G1/S phase transition. Cyclin D protein is anywhere from 155 to 477 amino acids in length.

<span class="mw-page-title-main">Cyclin-dependent kinase 2</span> Protein-coding gene in the species Homo sapiens

Cyclin-dependent kinase 2, also known as cell division protein kinase 2, or Cdk2, is an enzyme that in humans is encoded by the CDK2 gene. The protein encoded by this gene is a member of the cyclin-dependent kinase family of Ser/Thr protein kinases. This protein kinase is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, also known as Cdk1 in humans. It is a catalytic subunit of the cyclin-dependent kinase complex, whose activity is restricted to the G1-S phase of the cell cycle, where cells make proteins necessary for mitosis and replicate their DNA. This protein associates with and is regulated by the regulatory subunits of the complex including cyclin E or A. Cyclin E binds G1 phase Cdk2, which is required for the transition from G1 to S phase while binding with Cyclin A is required to progress through the S phase. Its activity is also regulated by phosphorylation. Multiple alternatively spliced variants and multiple transcription initiation sites of this gene have been reported. The role of this protein in G1-S transition has been recently questioned as cells lacking Cdk2 are reported to have no problem during this transition.

<span class="mw-page-title-main">Cyclin-dependent kinase 4</span> Human protein

Cyclin-dependent kinase 4 (CDK4), also known as cell division protein kinase 4, is an enzyme that is encoded by the CDK4 gene in humans. CDK4 is a member of the cyclin-dependent kinase family, a group of serine/threonine kinases which regulate the cell cycle. CDK4 regulates the G1/S transition by contributing to the phosphorylation of retinoblastoma (RB) protein, which leads to the release of protein factors like E2F1 that promote S-phase progression. It is regulated by cyclins like cyclin D proteins, regulatory kinases, and cyclin kinase inhibitors (CKIs). Dysregulation of the CDK4 pathway is common in many cancers, and CDK4 is a new therapeutic target in cancer treatment.

The Cyclin D/Cdk4 complex is a multi-protein structure consisting of the proteins Cyclin D and cyclin-dependent kinase 4, or Cdk4, a serine-threonine kinase. This complex is one of many cyclin/cyclin-dependent kinase complexes that are the "hearts of the cell-cycle control system" and govern the cell cycle and its progression. As its name would suggest, the cyclin-dependent kinase is only active and able to phosphorylate its substrates when it is bound by the corresponding cyclin. The Cyclin D/Cdk4 complex is integral for the progression of the cell from the Growth 1 phase to the Synthesis phase of the cell cycle, for the Start or G1/S checkpoint.

A series of biochemical switches control transitions between and within the various phases of the cell cycle. The cell cycle is a series of complex, ordered, sequential events that control how a single cell divides into two cells, and involves several different phases. The phases include the G1 and G2 phases, DNA replication or S phase, and the actual process of cell division, mitosis or M phase. During the M phase, the chromosomes separate and cytokinesis occurs.

The Start point is a major cell cycle checkpoint in yeast, known as the restriction point in multicellular organisms. The Start checkpoint ensures cell-cycle entry even if conditions later become unfavorable. The physiological factors that control passage through the Start checkpoint include external nutrient concentrations, presence of mating factor/ pheromone, forms of stress, and size control.

<span class="mw-page-title-main">Retinoblastoma protein</span> Mammalian protein found in humans

The retinoblastoma protein is a tumor suppressor protein that is dysfunctional in several major cancers. One function of pRb is to prevent excessive cell growth by inhibiting cell cycle progression until a cell is ready to divide. When the cell is ready to divide, pRb is phosphorylated, inactivating it, and the cell cycle is allowed to progress. It is also a recruiter of several chromatin remodeling enzymes such as methylases and acetylases.

Clb5 and Clb6 are B-type, S-phase cyclins in yeast that assist in cell cycle regulation. Clb5 and Clb6 bind and activate Cdk1, and high levels of these cyclins are required for entering S-phase. S-phase cyclin binding to Cdk1 directly stimulates DNA replication as well as progression to the next phase of the cell cycle.

<span class="mw-page-title-main">DNA re-replication</span> Undesirable occurrence in eukaryotic cells

DNA re-replication is an undesirable and possibly fatal occurrence in eukaryotic cells in which the genome is replicated more than once per cell cycle. Rereplication is believed to lead to genomic instability and has been implicated in the pathologies of a variety of human cancers. To prevent rereplication, eukaryotic cells have evolved multiple, overlapping mechanisms to inhibit chromosomal DNA from being partially or fully rereplicated in a given cell cycle. These control mechanisms rely on cyclin-dependent kinase (CDK) activity. DNA replication control mechanisms cooperate to prevent the relicensing of replication origins and to activate cell cycle and DNA damage checkpoints. DNA rereplication must be strictly regulated to ensure that genomic information is faithfully transmitted through successive generations.

Whi5 is a transcriptional regulator in the budding yeast, notably in the G1 phase. It plays an important role in cell size control in G1 phase, similarly with Retinoblastoma (Rb) protein in human, although the two have no similarity in sequence Whi5 is an inhibitor of SBF, which is involved in the transcription of G1-specific genes. Cln3 promotes the disassociation of Whi5 from SBF, and its disassociation results in the transcription of genes needed to enter S phase.

The Neuronal cell cycle represents the life cycle of the biological cell, its creation, reproduction and eventual death. The process by which cells divide into two daughter cells is called mitosis. Once these cells are formed they enter G1, the phase in which many of the proteins needed to replicate DNA are made. After G1, the cells enter S phase during which the DNA is replicated. After S, the cell will enter G2 where the proteins required for mitosis to occur are synthesized. Unlike most cell types however, neurons are generally considered incapable of proliferating once they are differentiated, as they are in the adult nervous system. Nevertheless, it remains plausible that neurons may re-enter the cell cycle under certain circumstances. Sympathetic and cortical neurons, for example, try to reactivate the cell cycle when subjected to acute insults such as DNA damage, oxidative stress, and excitotoxicity. This process is referred to as “abortive cell cycle re-entry” because the cells usually die in the G1/S checkpoint before DNA has been replicated.

<span class="mw-page-title-main">Cyclin E/Cdk2</span>

The Cyclin E/Cdk2 complex is a structure composed of two proteins, cyclin E and cyclin-dependent kinase 2 (Cdk2). Similar to other cyclin/Cdk complexes, the cyclin E/Cdk2 dimer plays a crucial role in regulating the cell cycle, with this specific complex peaking in activity during the G1/S transition. Once the cyclin and Cdk subunits join together, the complex gets activated, allowing it to phosphorylate and bind to downstream proteins to ultimately promote cell cycle progression. Although cyclin E can bind to other Cdk proteins, its primary binding partner is Cdk2, and the majority of cyclin E activity occurs when it exists as the cyclin E/Cdk2 complex.

References

  1. 1 2 Bartek J, Lukas J (February 2001). "Pathways governing G1/S transition and their response to DNA damage". FEBS Letters. 490 (3): 117–22. Bibcode:2001FEBSL.490..117B. doi:10.1016/S0014-5793(01)02114-7. PMID   11223026. S2CID   16090531.
  2. 1 2 3 4 Bertoli C, Skotheim JM, de Bruin RA (August 2013). "Control of cell cycle transcription during G1 and S phases". Nature Reviews Molecular Cell Biology. 14 (8): 518–28. doi:10.1038/nrm3629. PMC   4569015 . PMID   23877564.
  3. Massagué J (November 2004). "G1 cell-cycle control and cancer". Nature. 432 (7015): 298–306. Bibcode:2004Natur.432..298M. doi:10.1038/nature03094. PMID   15549091. S2CID   4428026.
  4. Bartek J, Lukas J (February 2001). "Pathways governing G1/S transition and their response to DNA damage". FEBS Letters. 490 (3): 117–22. Bibcode:2001FEBSL.490..117B. doi:10.1016/S0014-5793(01)02114-7. PMID   11223026. S2CID   16090531.
  5. Lodish H, Berk A, Kaiser C, Krieger M (2012). Molecular Cell Biology (7th ed.). Freeman, W. H. & Company. ISBN   978-1-4641-0981-2.
  6. Tenga MJ, Lazar IM (January 2013). "Proteomic snapshot of breast cancer cell cycle: G1/S transition point". Proteomics. 13 (1): 48–60. doi:10.1002/pmic.201200188. PMC   4123745 . PMID   23152136.
  7. 1 2 3 4 5 6 7 Lodish H, Berk A, Kaiser C, Krieger M (2012). Molecular Cell Biology (7th 13 ed.). Freeman, W. H. & Company. ISBN   978-1-4641-0981-2.
  8. Darzynkiewicz, Z; Sharpless, T; Staiano-Coico, L; Melamed, MR (1980). "Subcompartments of the G1 phase of cell cycle detected by flow cytometry". Proceedings of the National Academy of Sciences of the United States of America. 77 (11): 6696–9. Bibcode:1980PNAS...77.6696D. doi: 10.1073/pnas.77.11.6696 . PMC   350355 . PMID   6161370.
  9. "Phases of the Cell Cycle". KhanAcademy.
  10. Yeager, Randi; Bushkin, G. Guy; Singer, Emily; Fu, Rui; Cooperman, Benjamin; McMurray, Michael (2021-08-17). "Post-Transcriptional Control of Mating-Type Gene Expression during Gametogenesis in Saccharomyces cerevisiae". Biomolecules. 11 (8): 1223. doi: 10.3390/biom11081223 . ISSN   2218-273X. PMC   8394074 . PMID   34439889.
  11. 1 2 3 Alao JP (April 2007). "The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention". Molecular Cancer. 6: 24. doi: 10.1186/1476-4598-6-24 . PMC   1851974 . PMID   17407548.
  12. Poli A (2015). New DAG-dependent mechanisms modulate cell cycle progression [Dissertation]. Scienze Biomediche (Doctoral Thesis). doi:10.6092/unibo/amsdottorato/6739.
  13. Fadila, Guessous; Jinho, Heo; Vaddadi, Naga; Abbas, Tarek (2015). "Abstract 3786: Novel regulation of cyclin D1 stability and the DNA damage response". Cancer Research. 75 (15 Supplement): 3786. doi:10.1158/1538-7445.AM2015-3786.
  14. 1 2 3 Johnson, Amy; Skotheim, Jan M (2013-12-01). "Start and the restriction point". Current Opinion in Cell Biology. Cell cycle, differentiation and disease. 25 (6): 717–723. doi:10.1016/j.ceb.2013.07.010. ISSN   0955-0674. PMC   3836907 . PMID   23916770.
  15. Wang X, Simpson ER, Brown KA (December 2015). "p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis". Cancer Research. 75 (23): 5001–7. doi:10.1158/0008-5472.CAN-15-0563. PMID   26573797.